Sarcoid-like lesions obfuscating the diagnosis of disseminated Mycobacterium genavense infection in a patient with IL-12Rβ1-associated immunodeficiency.
Adult
Female
Humans
Immunologic Deficiency Syndromes
/ complications
Interferon Type I
Lymphadenopathy
/ complications
Male
Mycobacterium
Mycobacterium Infections
/ complications
Mycobacterium Infections, Nontuberculous
/ complications
Nontuberculous Mycobacteria
/ genetics
Receptors, Interleukin-12
/ genetics
Sarcoidosis
/ diagnosis
Case report
IL-12Rβ1 deficiency
Interferonopathy
Mycobacterium genavense
Sarcoid-like reaction
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
04 Oct 2022
04 Oct 2022
Historique:
received:
27
04
2022
accepted:
24
07
2022
entrez:
3
10
2022
pubmed:
4
10
2022
medline:
6
10
2022
Statut:
epublish
Résumé
Sarcoidosis is a systemic inflammatory disease that is characterized by non-caseating epithelioid-cell granulomas upon histology. However, similar histological findings may also be seen with certain infections. Thus, differentiation from infection is pivotal to ensure appropriate treatment. Here, we present a case of a disseminated infection with Mycobacterium genavense owing to an interleukin 12 receptor subunit beta 1 (IL-12Rβ1) associated immunodeficiency in a previously healthy female who was initially misdiagnosed with sarcoidosis. M. genavense is a nontuberculous mycobacterium which can cause lymphadenopathy, gastrointestinal and bone marrow infiltration in immunocompromised patients. With this case report we aim to highlight that an infection with M. genavense on the ground of a genetic defect of mycobacterial immune control may represent a rare differential diagnosis of sarcoidosis. A 31-year-old female was referred to our hospital with progressive lymphadenopathy, hepatosplenomegaly, pancytopenia and systemic inflammation. She had previously been evaluated for generalized lymphadenopathy in another hospital. At that time, lymph node biopsies had revealed sarcoid-like lesions and a systemic corticosteroid treatment was initiated based on a putative diagnosis of sarcoidosis. When her condition worsened, she was transferred to our university clinic, where the diagnosis of disseminated M. genavense infection owing to an inborn interferonopathy was made. Her family history revealed that her brother had also suffered from IL-12Rβ1 deficiency and had died from a systemic infection with M. genavense at the age of 21. The patient received antimycobacterial treatment combined with subcutaneous type I interferon, which eventually led to a gradual improvement over the next months. Differentiating between sarcoidosis and sarcoid-like lesions secondary to infections may be challenging, especially when pathogens are difficult to detect or not expected in an apparently immunocompetent patient. Patients with IL-12Rβ1-associated immunodeficiency may be asymptomatic until adulthood, and disseminated M. genavense infection on the grounds of an IL-12Rβ1-associated immunodeficiency may represent a rare differential diagnosis of sarcoidosis.
Sections du résumé
BACKGROUND
BACKGROUND
Sarcoidosis is a systemic inflammatory disease that is characterized by non-caseating epithelioid-cell granulomas upon histology. However, similar histological findings may also be seen with certain infections. Thus, differentiation from infection is pivotal to ensure appropriate treatment. Here, we present a case of a disseminated infection with Mycobacterium genavense owing to an interleukin 12 receptor subunit beta 1 (IL-12Rβ1) associated immunodeficiency in a previously healthy female who was initially misdiagnosed with sarcoidosis. M. genavense is a nontuberculous mycobacterium which can cause lymphadenopathy, gastrointestinal and bone marrow infiltration in immunocompromised patients. With this case report we aim to highlight that an infection with M. genavense on the ground of a genetic defect of mycobacterial immune control may represent a rare differential diagnosis of sarcoidosis.
CASE PRESENTATION
METHODS
A 31-year-old female was referred to our hospital with progressive lymphadenopathy, hepatosplenomegaly, pancytopenia and systemic inflammation. She had previously been evaluated for generalized lymphadenopathy in another hospital. At that time, lymph node biopsies had revealed sarcoid-like lesions and a systemic corticosteroid treatment was initiated based on a putative diagnosis of sarcoidosis. When her condition worsened, she was transferred to our university clinic, where the diagnosis of disseminated M. genavense infection owing to an inborn interferonopathy was made. Her family history revealed that her brother had also suffered from IL-12Rβ1 deficiency and had died from a systemic infection with M. genavense at the age of 21. The patient received antimycobacterial treatment combined with subcutaneous type I interferon, which eventually led to a gradual improvement over the next months.
CONCLUSIONS
CONCLUSIONS
Differentiating between sarcoidosis and sarcoid-like lesions secondary to infections may be challenging, especially when pathogens are difficult to detect or not expected in an apparently immunocompetent patient. Patients with IL-12Rβ1-associated immunodeficiency may be asymptomatic until adulthood, and disseminated M. genavense infection on the grounds of an IL-12Rβ1-associated immunodeficiency may represent a rare differential diagnosis of sarcoidosis.
Identifiants
pubmed: 36192705
doi: 10.1186/s12879-022-07644-4
pii: 10.1186/s12879-022-07644-4
pmc: PMC9531490
doi:
Substances chimiques
Interferon Type I
0
Receptors, Interleukin-12
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
770Informations de copyright
© 2022. The Author(s).
Références
Hum Mol Genet. 2005 Dec 15;14(24):3847-55
pubmed: 16293671
Am J Respir Cell Mol Biol. 2011 Nov;45(5):899-905
pubmed: 21659662
Semin Immunol. 2014 Dec;26(6):454-70
pubmed: 25453225
Patholog Res Int. 2014;2014:371370
pubmed: 24693456
Crit Rev Clin Lab Sci. 2018 May;55(3):184-204
pubmed: 29502462
Immunol Rev. 2015 Mar;264(1):182-203
pubmed: 25703560
Balkan Med J. 2013 Mar;30(1):13-5
pubmed: 25207061
J Clin Microbiol. 1996 Jul;34(7):1840-2
pubmed: 8784607
Int J Syst Bacteriol. 1993 Oct;43(4):841-3
pubmed: 8240965
Clin Microbiol Infect. 2018 Dec;24(12):1355-1356
pubmed: 30036670
J Clin Microbiol. 1995 Sep;33(9):2514-5
pubmed: 7494064
Medicine (Baltimore). 2010 Nov;89(6):381-402
pubmed: 21057261
Infect Dis (Lond). 2018 May;50(5):329-339
pubmed: 29157060
N Engl J Med. 2021 Sep 9;385(11):1018-1032
pubmed: 34496176
Scand J Infect Dis. 1999;31(1):63-8
pubmed: 10381220
Clin Microbiol Infect. 2022 Mar 11;:
pubmed: 35283318
Am J Respir Crit Care Med. 2020 Apr 15;201(8):e26-e51
pubmed: 32293205